Researchers examined data on side effects reported to the U.S. Food
and Drug Administration (FDA) from 2004 to 2016 for products like
makeup, sunscreen, tattoos, hair color, perfume, shaving creams and
baby care items. Overall, there were a total of 5,144 adverse
events, with an average of 396 a year, researchers report in JAMA
Internal Medicine.
Side effect reports climbed 78 percent to 706 in 2015, followed by a
300 percent surge to 1,591 adverse events last year, largely driven
by complaints about hair care products and WEN products in
particular, the study found.
"Adverse events to cosmetics matter to patients mostly because
nearly everyone uses a cosmetic or personal care product every
single day - this includes newborns, infants and pregnant women,"
said senior study author Dr. Shuai Xu, a dermatology researcher at
Northwestern University Feinberg School of Medicine in Chicago.
"Unlike drugs and medical devices, cosmetics permeate daily life,"
Xu said by email. "We're exposed to hundreds of chemicals a day from
these products."
For the study, Xu and colleagues examined adverse events data in the
FDA's Center for Food Safety and Applied Nutrition’s Adverse Event
Reporting System (CFSAN), a repository made publicly available in
2016. It includes voluntary reports of side effects submitted by
consumers and health care professionals.
The three most commonly reported products were hair care, skin care
and tattoos. Products that most often involved reports of serious
health problems were baby items, which accounted for about half of
these cases, followed by personal cleanliness supplies, hair care
and hair color.
Hair products, including shampoos, conditioners and styling aids,
accounted for 35 percent of all adverse event reports, followed by
skin care products, which made up 22 percent of the complaints.
In 2014, the FDA began investigating WEN by Chaz Dean Cleansing
Conditioners after directly receiving 127 consumer reports,
researchers note.
Later, the FDA learned that the manufacturer had already received
21,000 complaints of alopecia and scalp irritation. Hair loss was
also reported by consumers. The product remains on the market with
the FDA currently seeking additional consumer reports.
[to top of second column] |
Limitations of the study include the lack of data on what caused
side effects, the authors note. Researchers were also unable to
distinguish between reports from consumers and from health
professionals.
It's also possible that the study underestimates the total number of
adverse events or the number of serious side effects because
reporting isn't mandatory and companies and manufacturers are not
required to share complaints they receive with the FDA, the authors
note.
The results suggest that better cosmetic surveillance is needed, the
researchers conclude.
Approaches that might help include registering new products with the
FDA so regulators know what's out there; making it mandatory for
companies to report adverse events to the FDA, and increased funding
for the FDA to investigate problems, former FDA commissioner Dr.
Robert Califf and colleagues write in an accompanying editorial.
In the meantime, consumers should read labels carefully, Califf, now
a professor at Duke University School of Medicine in Durham, North
Carolina, said by email.
"There is little direct protection, but consumers should read
labels, understand what they are buying and focus on companies with
established reputations for quality," Califf said.
A spokesperson for WEN by Chaz Dean styling products told Reuters
Health in a statement, “The WEN family cares deeply about our
customers. There has been no credible evidence presented to support
the false and misleading claims that WEN products cause hair loss .
. . WEN by Chaz Dean has been proven safe, and millions of bottles
have been sold over the last 16 years. We have consistently
cooperated with the FDA and will continue to do so.”
SOURCE: http://bit.ly/2td6imM JAMA Internal Medicine, online June
26, 2017.
[© 2017 Thomson Reuters. All rights
reserved.] Copyright 2017 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed. |